✦ LIBER ✦

Terminal deoxynucleotidyl transferase activity in a cell line (Molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia

✍ Scribed by B.I.Sahai Srivastava; J. Minowada

Book ID: 118854520
Publisher: Elsevier Science
Year: 1973
Tongue: English
Weight: 372 KB
Volume: 51
Category: Article
ISSN: 0006-291X
DOI: 10.1016/0006-291x(73)91346-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surveillance of terminal deoxynucleotidy

Surveillance of terminal deoxynucleotidyl transferase (TdT)-containing cells in peripheral blood of patients with acute lymphoblastic leukemia (ALL)

✍ M.L. Hetherington; P.R. Huntsman; R.G. Smith; G.R. Buchanan 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Characterization of terminal deoxynucleo

Characterization of terminal deoxynucleotidyltransferase in a cell line (8402) derived from a patient with acute lymphoblastic leukemia

✍ P.S. Sarin; R.C. Gallo 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Establishment of the amsalem T-cell line

Establishment of the amsalem T-cell line from a patient with acute lymphoblastic leukemia. Expression of E-receptor-associated antigens in cells incapable of forming E-rosettes

✍ H. Ben Bassat; R. Rabinowitz; A. Polliack; R. Hadar; M. Schlesinger 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 French ⚖ 735 KB

## Abstract A new T‐cell line (Amsalem) was established from the peripheral blood of a patient with pre‐T leukemia. Amsalem cells are unique in that they possess antigenic determinants associated with the E‐receptor, yet fail to form rosettes with sheep red blood cells (SRBC). Amsalem cells were fo

Platelet-activating factor changes in ph

Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia — A31P MRSin vitrostudy

✍ Małgorzata Kuliszkiewicz-Janus; Mariusz Adam Tuz; Marek Kiełbiński; Stanisław Ba 📂 Article 📅 2008 🏛 SP Versita 🌐 English ⚖ 611 KB

## Abstract The aim of this investigation was to evaluate the changes in PAF concentrations in the plasma, PBMC and BMMC of patients with acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML). The plasma was from 23 healthy volunteers (HV) and 44 patients with AL (16 ALL, 28 AML)